To include your compound in the COVID-19 Resource Center, submit it here.

CVTX down on CARISA update

CV Therapeutics was off $21.25 (35 percent) to $39.625 on Friday after announcing it will

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE